Related Experiment Video
Updated: Jan 8, 2026

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
2.2K
Neurosymbolic Digital Twin for Cardiovascular Disease Prediction and Personalized Modeling
IEEE Journal of Biomedical and Health Informatics
|December 23, 2025
Summary
NeuroTwin, a novel neurosymbolic digital twin, enhances cardiovascular care by integrating advanced AI modules for precise diagnostics and personalized treatment planning. It achieves high accuracy while ensuring patient privacy and causal explainability.
Area of Science:
- Biomedical Engineering
- Artificial Intelligence in Medicine
- Computational Cardiology
Background:
- Cardiovascular disease management necessitates accurate diagnostics, causal understanding, personalized treatments, and data privacy.
- Existing clinical decision frameworks often lack integration of these critical components.
Purpose of the Study:
- To introduce NeuroTwin, a neurosymbolic digital twin designed for unified cardiovascular clinical decision-making.
- To evaluate NeuroTwin's efficacy in diagnostic precision, treatment optimization, causal explainability, and privacy preservation.
Main Methods:
- NeuroTwin integrates four modules: adaptive diffusion transformer (ADViT) for signal denoising and fusion, symbolic causal discovery network (SCDN) for causal graph construction, neural federated digital twin (NFDT) for private distributed learning, and hierarchical meta-reinforcement learner (HMRL) for treatment recommendations.
- ADViT utilizes patch-level encoding and cross-modal fusion for ECG/PCG signals.
- SCDN employs differentiable acyclicity constraints for rule generation.
- NFDT uses differentially private Gaussian aggregation for federated learning.
- HMRL implements a bi-level policy for treatment optimization.
Main Results:
- NeuroTwin demonstrated 98.5% diagnostic precision and 96.2% success in treatment optimization.
- A causal explainability score of 0.942 was achieved.
- The system maintained a low privacy leakage rate of 0.032.
Conclusions:
- NeuroTwin offers a robust, integrated framework for advanced cardiovascular prediction and therapy planning.
- The system effectively balances diagnostic accuracy, treatment personalization, causal transparency, and data privacy.
- NeuroTwin represents a significant advancement in AI-driven clinical decision support for cardiovascular care.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Model Approaches for Pharmacokinetic Data: Physiological Models
234
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
234

